JAK-STAT Domain Enhanced MUC1-CAR-T Cells Induced Esophageal Cancer Elimination 继续阅读JAK-STAT Domain Enhanced MUC1-CAR-T Cells Induced Esophageal Cancer Elimination
Chimeric cytokine receptor enhancing PSMA-CAR-T cell-mediated prostate cancer regression 继续阅读Chimeric cytokine receptor enhancing PSMA-CAR-T cell-mediated prostate cancer regression
Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager 继续阅读Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager
Development of GPC3 and EGFR-dual-targeting chimeric antigen receptor-T cells for adoptive T cell therapy 继续阅读Development of GPC3 and EGFR-dual-targeting chimeric antigen receptor-T cells for adoptive T cell therapy
Selective Targeting of Glioblastoma with EGFRvIII/EGFR Bitargeted Chimeric Antigen Receptor T Cell 继续阅读Selective Targeting of Glioblastoma with EGFRvIII/EGFR Bitargeted Chimeric Antigen Receptor T Cell
Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer 继续阅读Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer
Treatment Efficacy of Chuang Ling Ye, a Traditional Chinese Herbal Medicine Compound, on Idiopathic Granulomatous Mastitis: A Randomized Controlled Trial 继续阅读Treatment Efficacy of Chuang Ling Ye, a Traditional Chinese Herbal Medicine Compound, on Idiopathic Granulomatous Mastitis: A Randomized Controlled Trial
Original research: Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells 继续阅读Original research: Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells
